KLH conjugated synthetic peptide derived from human Krox-20 (EGR2). Please contact us for the exact immunogen sequence. The peptide is available as orb13005.
Konjugation:
Unconjugated
Krox-20 (EGR2) antibody
Klonalität:
Polyclonal
Konzentration:
- 100 µg (in 200 µl): 0.5 mg/ml- 200 µg (in 400 µl): 0.5 mg/ml
Molekulargewicht:
50 kDa
Reinheit:
Polyclonal antibodies are purified by peptide affinity chromatography
Formulierung:
10 mM PBS, 0.02% sodium azide
Target-Kategorie:
Krox-20 (EGR2)
Application Verdünnung:
IHC-P: 1:100-500, WB: 1:200-2000
IHC-P staining of human breast tumour tissue using anti-Krox-20 (EGR2) (dilution at 2.5 ug/ml)
IHC-P staining of human breast tumour tissue using Krox-20 (EGR2) antibody (dilution at 2.5 ug/ml)
Immunohistochemical staining of paraffin embedded rat brain tissue using anti-Krox-20 (EGR2) (primary antibody at 2.5 ug/ml)
Immunohistochemical staining of paraffin embedded rat brain tissue using anti-Krox-20 (EGR2) (primary antibody at 2.5 ug/ml)
IHC-P staining of rat brain tissue using Krox-20 (EGR2) antibody (dilution at 2.5 ug/ml)
Immunohistochemical staining of paraffin embedded rat brain tissue using anti-Krox-20 (EGR2) (primary antibody at 2.5 ug/ml)
Western blot analysis of rat nerve (lane 1), mouse brain (lane 2), mouse spinal cord (lane 3), human breast cancer (lane 4), U251 cells (lane 5) using Krox-20 (EGR2) antibody
WB analysis of rat nerve (lane 1), mouse brain (lane 2), mouse spinal cord (lane 3), human breast cancer (lane 4), U251 cells (lane 5) using Krox-20 (EGR2) antibody
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten